REPL
#2206
Replimune Group, Inc. - Common Stock
15.5 0 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.64%
Variación mensual
+36.20%
Variación en los últimos 6 meses
+107.77%
Cambio anual
+180.80%
Cierres anteriores
15.6 0
Open
15.5 0
Mínimo
15.5 0
Máximo
15.5 0
Volumen
123
Financials
- Market Capitalization 1.46 B
- Employee 465
- Founded 2015
- CEO N/A
- Website www.replimune.com
- Headquarter Delaware, United States
- FIGI BBG00L8Z22R1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.51
Relación precio/flujo de caja
466.02
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2195 |  TYRA Tyra Biosciences, Inc. - Common Stock | 24.94 USD | -4.55% | -4.04% | -20.55% | +73.92% | 1.49 B USD | ||
| 2198 |  AVBP ArriVent BioPharma, Inc. - Common Stock | 30.17 USD | -2.68% | +3.96% | -0.40% | +55.92% | 1.49 B USD | ||
| 2236 |  CGEM Cullinan Therapeutics, Inc. - Common Stock | 21.70 USD | -3.98% | +0.37% | +25.07% | +189.33% | 1.40 B USD | ||
| 2247 |  ANRO Alto Neuroscience, Inc. Common Stock | 35.13 USD | -3.01% | +1.24% | +32.52% | +854.62% | 1.38 B USD |